Increased Access to Genetic Testing for Cancer Patients
This act aims to facilitate access to advanced genetic and laboratory tests for individuals diagnosed with cancer. This means Medicare, Medicaid, and CHIP health insurance will cover the costs of these tests, potentially leading to better treatment and disease monitoring. Additionally, the act includes an education program for healthcare professionals and the public on genetic testing.
Key points
Medicare, Medicaid, and CHIP will cover advanced genetic and laboratory tests for cancer patients, including DNA and RNA sequencing.
These tests will be available upon cancer diagnosis, recurrence, and for monitoring disease progression or treatment response.
The act establishes an education program for physicians and the public to raise awareness about genetic testing and its role in cancer care.
Expired
Citizen Poll